InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Ouzren Nawal, Director. Insider active across 1 company, notably Arena Pharmaceuticals INC. In total, 3 reports have been published. Activity tracked since 11 June 2021. The latest transaction was filed on 11 June 2021 (Attribution). Regulator: SEC (Form 4). All data is free.
3 of 3 declarations
Nawal Ouzren serves as a Director at ARENA PHARMACEUTICALS INC. She contributes to the company's governance and strategic decision-making. Her experience in the pharmaceutical sector is valuable to the board.